Clonidine in horses: identification, detection, and clinical pharmacology.

The research article focuses on the study of the drug Clonidine in horses, examining its performance-enhancing properties, detection methods, and its effects.

Introduction and Scope

• The research was conducted on the performance-enhancing drug Clonidine, mainly used in horse racing. Clonidine, classified as a significant grade performance-enhancing agent by the Association of Racing Commissioners International, possesses the ability to influence the outcome of a race significantly.
• The primary focus of the study is to comprehend Clonidine’s pharmacokinetic parameters, its method of detection and the clinical pharmacological impacts on horses.

Methodology

• A refined method was developed for the detection of Clonidine in horse plasma through a sensitive gas chromatograph and mass spectrometer. These instruments help in providing an accurate measurement of the drug in the biological system of the horse.
• A single dose (0.025 mg/kg) of Clonidine was injected intravenously into the horses for the study.

Results and Findings

• Post the administration of the drug, the horses exhibited rapid and profound sedation, indicating the immediate impact of the drug on the equine system creating a sedative effect.
• This sedative effect, however, was found to be quickly reversible with Yohimbine – a drug used as an antidote for Clonidine overdose.
• Furthermore, an analgesic effect was observed in the horses under the influence of Clonidine. This effect is a state of reduced pain sensitivity, rendering the horse immune to minor discomforts, acting as a form of analgesic.
• Despite this, in several cases, Clonidine failed to deliver maximum analgesia, meaning that it didn’t fully alleviate pain in all treated horses. This limited analgesic effect was found to last approximately 60 minutes before gradually fading.